Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program

BACKGROUND: Cutaneous adverse drug reactions (cADRs) can cause significant morbidity and distress in patients especially in the HIV infected population on antiretroviral therapy. Adverse Drug Reaction monitoring and ascertaining causality in resource limited settings still remains a challenge. This...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Mudzviti, Tinashe, Sibanda, Marvelous, Gavi, Samuel, Maponga, Charles Chiedza, Morse, Gene D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2012
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535441/
https://ncbi.nlm.nih.gov/pubmed/23277506
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk